(3S,5R,8R,9R,10R,13R,14R,15S,17S)-17-[(5S)-5,6-dimethylhepta-1,6-dien-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,15-diol

Details

Top
Internal ID 8961867c-aa43-4409-ba67-0db7f782671b
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Triterpenoids
IUPAC Name (3S,5R,8R,9R,10R,13R,14R,15S,17S)-17-[(5S)-5,6-dimethylhepta-1,6-dien-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,15-diol
SMILES (Canonical) CC(CCC(=C)C1CC(C2(C1CCC3C2(CCC4C3(CCC(C4(C)C)O)C)C)C)O)C(=C)C
SMILES (Isomeric) C[C@@H](CCC(=C)[C@H]1C[C@@H]([C@@]2([C@@H]1CC[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C)O)C(=C)C
InChI InChI=1S/C31H52O2/c1-19(2)20(3)10-11-21(4)22-18-27(33)31(9)23(22)12-13-25-29(7)16-15-26(32)28(5,6)24(29)14-17-30(25,31)8/h20,22-27,32-33H,1,4,10-18H2,2-3,5-9H3/t20-,22+,23+,24-,25+,26-,27-,29-,30+,31-/m0/s1
InChI Key NMNLJGFXOPDWLJ-RLJOBVSYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C31H52O2
Molecular Weight 456.70 g/mol
Exact Mass 456.396730897 g/mol
Topological Polar Surface Area (TPSA) 40.50 Ų
XlogP 9.30
Atomic LogP (AlogP) 7.55
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (3S,5R,8R,9R,10R,13R,14R,15S,17S)-17-[(5S)-5,6-dimethylhepta-1,6-dien-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,15-diol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9969 99.69%
Caco-2 - 0.5613 56.13%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.6143 61.43%
Subcellular localzation Mitochondria 0.4758 47.58%
OATP2B1 inhibitior - 0.5714 57.14%
OATP1B1 inhibitior + 0.9035 90.35%
OATP1B3 inhibitior + 0.8695 86.95%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7000 70.00%
BSEP inhibitior - 0.5450 54.50%
P-glycoprotein inhibitior - 0.6198 61.98%
P-glycoprotein substrate - 0.6452 64.52%
CYP3A4 substrate + 0.6865 68.65%
CYP2C9 substrate - 0.6499 64.99%
CYP2D6 substrate - 0.6843 68.43%
CYP3A4 inhibition - 0.7968 79.68%
CYP2C9 inhibition - 0.9229 92.29%
CYP2C19 inhibition - 0.7885 78.85%
CYP2D6 inhibition - 0.9488 94.88%
CYP1A2 inhibition - 0.8874 88.74%
CYP2C8 inhibition - 0.6594 65.94%
CYP inhibitory promiscuity - 0.5600 56.00%
UGT catelyzed - 0.7000 70.00%
Carcinogenicity (binary) - 0.9200 92.00%
Carcinogenicity (trinary) Non-required 0.6374 63.74%
Eye corrosion - 0.9916 99.16%
Eye irritation - 0.9144 91.44%
Skin irritation + 0.5158 51.58%
Skin corrosion - 0.9531 95.31%
Ames mutagenesis - 0.7437 74.37%
Human Ether-a-go-go-Related Gene inhibition + 0.7287 72.87%
Micronuclear - 0.9600 96.00%
Hepatotoxicity - 0.8125 81.25%
skin sensitisation + 0.5538 55.38%
Respiratory toxicity + 0.5667 56.67%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.9750 97.50%
Nephrotoxicity - 0.8087 80.87%
Acute Oral Toxicity (c) I 0.5667 56.67%
Estrogen receptor binding + 0.7163 71.63%
Androgen receptor binding + 0.7407 74.07%
Thyroid receptor binding + 0.6201 62.01%
Glucocorticoid receptor binding + 0.7489 74.89%
Aromatase binding + 0.6856 68.56%
PPAR gamma - 0.5100 51.00%
Honey bee toxicity - 0.7090 70.90%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity + 0.5600 56.00%
Fish aquatic toxicity + 0.9930 99.30%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.22% 96.09%
CHEMBL4040 P28482 MAP kinase ERK2 97.41% 83.82%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 96.98% 82.69%
CHEMBL253 P34972 Cannabinoid CB2 receptor 95.87% 97.25%
CHEMBL218 P21554 Cannabinoid CB1 receptor 95.43% 96.61%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 93.35% 94.45%
CHEMBL237 P41145 Kappa opioid receptor 93.01% 98.10%
CHEMBL206 P03372 Estrogen receptor alpha 92.99% 97.64%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.24% 97.09%
CHEMBL4072 P07858 Cathepsin B 90.22% 93.67%
CHEMBL2996 Q05655 Protein kinase C delta 89.75% 97.79%
CHEMBL233 P35372 Mu opioid receptor 89.66% 97.93%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 89.54% 89.05%
CHEMBL2581 P07339 Cathepsin D 89.09% 98.95%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 87.54% 95.89%
CHEMBL4685 P14902 Indoleamine 2,3-dioxygenase 87.30% 96.38%
CHEMBL4482 O96013 Serine/threonine-protein kinase PAK 4 86.34% 95.42%
CHEMBL240 Q12809 HERG 86.16% 89.76%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 85.92% 92.86%
CHEMBL6136 O60341 Lysine-specific histone demethylase 1 85.76% 95.58%
CHEMBL1937 Q92769 Histone deacetylase 2 85.70% 94.75%
CHEMBL2095194 P08709 Coagulation factor VII/tissue factor 85.29% 99.17%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.64% 95.89%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 84.61% 91.11%
CHEMBL5103 Q969S8 Histone deacetylase 10 84.60% 90.08%
CHEMBL221 P23219 Cyclooxygenase-1 84.30% 90.17%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.19% 100.00%
CHEMBL5469 Q14289 Protein tyrosine kinase 2 beta 83.76% 91.03%
CHEMBL4618 P09960 Leukotriene A4 hydrolase 82.32% 97.86%
CHEMBL2553 Q15418 Ribosomal protein S6 kinase alpha 1 81.46% 85.11%
CHEMBL2534 O15530 3-phosphoinositide dependent protein kinase-1 81.42% 95.36%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 81.36% 100.00%
CHEMBL2107 P61073 C-X-C chemokine receptor type 4 81.07% 93.10%
CHEMBL4835 P00338 L-lactate dehydrogenase A chain 81.04% 95.34%
CHEMBL3055 P50613 Cyclin-dependent kinase 7 81.02% 81.88%
CHEMBL4227 P25090 Lipoxin A4 receptor 80.95% 100.00%
CHEMBL5600 P27448 Serine/threonine-protein kinase c-TAK1 80.81% 88.81%
CHEMBL268 P43235 Cathepsin K 80.78% 96.85%

Cross-Links

Top
PubChem 101863232
NPASS NPC287430
LOTUS LTS0044346
wikiData Q105181879